Brader M L, Borchardt D, Dunn M F
Department of Biochemistry, University of California, Riverside 92521-0129.
Biochemistry. 1992 May 19;31(19):4691-6. doi: 10.1021/bi00134a023.
The R-state conformation of the Cu(II)-substituted insulin hexamer has been identified, and a number of its derivatives have been studied via 1H NMR, ESR, and UV-visible spectroscopy. This work establishes that the Cu(II)-substituted insulin hexamer undergoes an analogous T to R conformational transition in solution that has been identified previously for Zn(II)- and Co(II)-insulin hexamers [Roy, M., Brader, M.L., Lee, R. W.-K., Kaarsholm, N.C., Hansen, J., & Dunn, M.F. (1989) J. Biol. Chem. 264, 19081-19085]. The data indicate that each Cu(II) center of the R-state Cu(II)-insulin hexamer possesses a coordination site that is accessible to anions from solution. Both phenol and anionic ligands that coordinate to the Cu(II) ions are required to generate the necessary heterotropic interactions that stabilize the R-state structure. With phenylmethylthiolate (PMT), a Cu(II)-R6 adduct that displays the spectral features of blue (type 1) copper proteins is obtained. This complex is proposed to embody a pseudotetrahedral CuIIN3S(PMT) chromophore, in which N is HisB10 (imidazolyl). The remaining ligands examined gave rise to Cu(II)-R6 adducts that possessed the spectral characteristics of normal (type 2) Cu(II) proteins. Under reducing conditions, Cu(I)-T6 and Cu(I)-R6 hexamers have been identified.
已鉴定出铜(II)取代胰岛素六聚体的R态构象,并通过1H NMR、ESR和紫外可见光谱对其多种衍生物进行了研究。这项工作证实,铜(II)取代胰岛素六聚体在溶液中经历了类似的从T态到R态的构象转变,这一转变先前已在锌(II)和钴(II)胰岛素六聚体中得到鉴定[Roy, M., Brader, M.L., Lee, R. W.-K., Kaarsholm, N.C., Hansen, J., & Dunn, M.F. (1989) J. Biol. Chem. 264, 19081 - 19085]。数据表明,R态铜(II)-胰岛素六聚体的每个铜(II)中心都有一个可供溶液中阴离子接近的配位位点。与铜(II)离子配位的苯酚和阴离子配体都需要产生稳定R态结构所需的异质相互作用。使用苯甲硫醇盐(PMT),可得到一种显示蓝色(1型)铜蛋白光谱特征的铜(II)-R6加合物。该配合物被认为包含一个假四面体CuIIN3S(PMT)发色团,其中N为HisB10(咪唑基)。所研究的其余配体产生了具有正常(2型)铜(II)蛋白光谱特征的铜(II)-R6加合物。在还原条件下,已鉴定出铜(I)-T6和铜(I)-R6六聚体。